Dillon Adrian T. - 25 Aug 2026 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Reporting relationship: Director
Issuer ticker: HQY
Reported as of: 25 Aug 2026
Net transaction value: -$798,373
SEC form: 4
Accepted by SEC: 27 Aug 2026, 17:04:02 UTC
Prior SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Newton , Attorney-in-Fact

Key filing fact

Dillon Adrian T. filed Form 4 for HEALTHEQUITY, INC. (HQY) on 27 Aug 2026.

Key facts

This page summarizes Dillon Adrian T.'s Form 4 filing for HEALTHEQUITY, INC. (HQY).
4 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 27 Aug 2026, 17:04.

Change

Previous filing in this sequence was filed on 29 Jun 2026.
Current net transaction value: -$798,373.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001163402 Primary reporting owner

DILLON ADRIAN T

Relationship: Director
Address: C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER
Signature: /s/ Michael Newton , Attorney-in-Fact
Signature date: 27 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,632
Change %: +12%
Price: $32.50^*
Shares after: 70,027
Date: 25 Aug 2026
Ownership: Direct
Footnotes: F1

HQY transaction

Common Stock

Sale

Transaction value: $658,172
Shares: -6,300
Change %: -9%
Price: $104.47
Shares after: 63,727
Date: 25 Aug 2026
Ownership: Direct
Footnotes: F1, F2

HQY transaction

Common Stock

Sale

Transaction value: $140,201
Shares: -1,332
Change %: -2.1%
Price: $105.26
Shares after: 62,395
Date: 25 Aug 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HQY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -7,632
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,632
Exercise price: $32.50
Footnotes: F1, F4

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,837
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,837
Exercise price: $46.40
Footnotes: F4

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,339
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,339
Exercise price: $50.41
Footnotes: F4

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,626
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,626
Exercise price: $63.64
Footnotes: F4

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,012
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,012
Exercise price: $66.06
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.10 to $105.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 of this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.10 to $105.53, inclusive.

Footnote F4

The option is immediately exercisable.

SEC remarks

The Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission on February 5, 2024, as an exhibit to a statement on Form 4 filed by Mr. Dillon with respect to HealthEquity, Inc. and is hereby incorporated by reference.